Cardiovascular pathology in HIV infection

Abstract

Currently, there are indications of an increase in the incidence of cardiovascular pathology in patients with HIV infection in comparison with population data and a higher mortality rate from cardiovascular diseases. The problem of detecting the pathology of the cardiovascular system in patients infected with the human immunodeficiency virus (HIV) is relevant due to the increase in the number of HIV-positive individuals and the established effect of HIV infection on the circulatory organs. In order to identify cardiovascular pathology, two patients with stages III and IV of HIV infection were extensively examined. The examination was carried out using electrocardiography, echocardiography and ultrasound dopplerography. Both clinical cases are presented below, in which pronounced cardiovascular pathology was detected in both cases. As factors influencing the development of pathology of the cardiovascular system, based on the presented clinical examples, drug addiction (long-term intravenous use of surfactants) and pathologies of other internal organs in the development of HIV-mediated opportunistic diseases are considered. Analysis of the course of the disease showed that the lesion can develop in various stages of HIV infection, more often infectious endocarditis is the main diagnosis in patients in stage 3 of HIV infection (the first clinical example), and dilated cardiomyopathy — in the late stages of HIV infection and is considered as a concomitant pathology due to lung and kidney damage (the second clinical example).

Keywords

HIV infection / cardiac pathology / case report

References

[1] French AL, Gawel SH, Hershow R, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr. 2009;51(4):339–406. doi: 10.1097/QAI.0b013e3181acb4e5

[2] French A.L., Gawel S.H., Hershow R., et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study // J Acquir Immune Defic Syndr. 2009. Vol. 51, N 4. Р. 339–406. doi: 10.1097/QAI.0b013e3181acb4e5

[3] Knobel H, Jerico C, Montero M, et al. Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations. Framingham SCORE and PROCAM. AIDS Patient Care. 2007;21(7):452–457. doi: 10.1089/apc.2006.0165

[4] Knobel H., Jerico C., Montero M., et al. Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations. (Framingham SCORE and PROCAM) // AIDS Patient Care. 2007. Vol. 21, N 7. Р. 452–457. doi: 10.1089/apc.2006.0165

[5] Savès M, Chêne G, Ducimetière P, et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis. 2003;37(2):292–298. doi: 10.1086/375844

[6] Savès M., Chêne G., Ducimetière P., et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population // Clin Infect Dis. 2003. Vol. 37, N 2. Р. 292–298. doi: 10.1086/375844

[7] Klein D, Leyden W, Xu L. Contribution of immunodeficiency to CHD: cohort study of HIV+ and HIV- Kaiser Permanente members. 18th Conference on Retroviruses and Opportunistic Infections. Boston; 2011. Abstract 810.

[8] Klein D., Leyden W., Xu L. Contribution of immunodeficiency to CHD: cohort study of HIV+ and HIV- Kaiser Permanente members. 18th Conference on Retroviruses and Opportunistic Infections. Boston, 2011. Abstract 810.

[9] Mudritskaya TN, Turna EYu, Zakharova MA, Grigorenko EI. Damage to the cardiovascular system in HIV infection. Crimean Therapeutic Journal. 2014;(2):82–88. (In Russ).

[10] Мудрицкая Т.Н., Турна Э.Ю., Захарова М.А., Григоренко Е.И. Поражение сердечно-сосудистой системы при ВИЧ-инфекции // Крымский терапевтический журнал. 2014. № 2. С. 82–88.

[11] Matievskaya NV, Tokunova IO, Snezhitsky VA. HIV-infection and pathology of the cardiovascular system. Medical News. 2015;249(6):6–12. (In Russ).

[12] Матиевская Н.В., Токунова И.О., Снежицкий В.А. ВИЧ-инфекция и патология сердечно-сосудистой системы // Медицинские новости. 2015. Т. 249, № 6. С. 6–12.

[13] Mozgaleva NV, Parkhomenko YuG. Morphofunctional parallels of changes in the conduction system of the heart and working myocardium in infective endocarditis and generalized tuberculosis in the presence of drug addiction and HIV infection. Annals of Arrhythmology. 2017;14(2):81–89. (In Russ).

[14] Мозгалева Н.В., Пархоменко Ю.Г. Морфофункциональные параллели изменений проводящей системы сердца и рабочего миокарда при инфекционном эндокардите и генерализованном туберкулезе на фоне наркомании и ВИЧ-инфекции // Анналы аритмологии. 2017. Т. 14, № 2. С. 81–89.

RIGHTS & PERMISSIONS

Eco-vector